<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19213" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Ceruloplasmin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lopez</surname>
            <given-names>Michael J.</given-names>
          </name>
          <aff>Augusta Un., Medical College of Georgia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Royer</surname>
            <given-names>Amor</given-names>
          </name>
          <aff>University of Mississippi Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Niraj J.</given-names>
          </name>
          <aff>University Of Mississippi Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Lopez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amor Royer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Niraj Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19213.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Ceruloplasmin is&#x000a0;a serum ferroxidase responsible for&#x000a0;95% copper transport in the blood.&#x000a0;It is well known for its role in the pathogenesis of&#x000a0;Wilson disease and regulating iron metabolism.<xref ref-type="bibr" rid="article-19213.r1">[1]</xref>&#x000a0;Also, ceruloplasmin is a positive acute-phase reactant, meaning its levels increase in inflammatory conditions or cell injury.<xref ref-type="bibr" rid="article-19213.r2">[2]</xref>&#x000a0;Copper is a trace element that acts as a cofactor for multiple enzymes in critical cellular reactions, such as cytochromes, which participate in the electron transport chain and redox catalysis.<xref ref-type="bibr" rid="article-19213.r3">[3]</xref>&#x000a0;Recent studies have shown that alterations of ceruloplasmin protein and copper homeostasis are associated with Alzheimer disease.<xref ref-type="bibr" rid="article-19213.r4">[4]</xref><xref ref-type="bibr" rid="article-19213.r5">[5]</xref></p>
      </sec>
      <sec id="article-19213.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>Ceruloplasmin&#x000a0;production occurs in the liver and is a ferroxidase enzyme encoded by the CP gene in humans.<xref ref-type="bibr" rid="article-19213.r6">[6]</xref> Liver hepatocytes predominantly synthesize ceruloplasmin. In the liver, P-type ATPase (ATPase 7B) enzymes are necessary to incorporate&#x000a0;copper into apo-ceruloplasmin.<xref ref-type="bibr" rid="article-19213.r7">[7]</xref>&#x000a0;Ceruloplasmin is then released into the bloodstream to transport properly to distal sites and to complete its functions in other metabolic processes, namely iron homeostasis and metabolism. A solution of ceruloplasmin is blue, and excess serum levels may give the serum a greenish hue. Each ceruloplasmin molecule can bind to 6 to 8 copper atoms; usually, 50% are in cupric (+2) and 50% are in cuprous (+1) states.<xref ref-type="bibr" rid="article-19213.r8">[8]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-19213.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>As an acute phase reactant, ceruloplasmin may elevate in multiple conditions such as trauma, tissue damage, infection, or inflammation. It bears mention that ceruloplasmin may increase in states of high estrogen and progesterone; for instance, pregnant women, patients receiving estrogen therapy, and women on oral contraceptives may have high levels of ceruloplasmin.<xref ref-type="bibr" rid="article-19213.r2">[2]</xref>&#x000a0;In addition, many medications, notably anti-seizure drugs (eg, valproic acid), are known to increase ceruloplasmin levels.<xref ref-type="bibr" rid="article-19213.r9">[9]</xref> Measurements of the ceruloplasmin level are not common in standard laboratory testing, but&#x000a0;certain symptoms may raise clinical suspicion and prompt the ordering of ceruloplasmin levels.<xref ref-type="bibr" rid="article-19213.r10">[10]</xref>&#x000a0;These include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anemia</p>
          </list-item>
          <list-item>
            <p>Ataxia</p>
          </list-item>
          <list-item>
            <p>Nausea and abdominal pain</p>
          </list-item>
          <list-item>
            <p>Neuropathy</p>
          </list-item>
          <list-item>
            <p>Jaundice</p>
          </list-item>
          <list-item>
            <p>Fatigue</p>
          </list-item>
          <list-item>
            <p>Behavioral changes</p>
          </list-item>
          <list-item>
            <p>Tremors</p>
          </list-item>
          <list-item>
            <p>Difficulty walking or swallowing</p>
          </list-item>
          <list-item>
            <p>Dystonia</p>
          </list-item>
          <list-item>
            <p>Sleep disorders</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19213.s4" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Ceruloplasmin is an enzyme from the multi-copper oxidase family. It is synthesized primarily in the liver parenchymal cells, with small amounts produced from immune cells, including macrophages and lymphocytes.<xref ref-type="bibr" rid="article-19213.r11">[11]</xref> The peptide chain is synthesized, and copper atoms are added from an intracellular ATPase.<xref ref-type="bibr" rid="article-19213.r12">[12]</xref>&#x000a0;Although copper availability is not necessary for ceruloplasmin translation, copper binding is essential for the adequate folding of ceruloplasmin protein and the normal attachment of side-chain oligosaccharides. The apo-ceruloplasmin, which does not contain copper or the ATPase, is less structurally stable, and most undergo intracellular degradation. However, a small portion of apo-enzyme reaches circulation&#x000a0;but&#x000a0;has a short half-life of 5&#x000a0;to 6 hours compared to the holoenzyme (ceruloplasmin plus copper), which has a longer half-life of a few days.<xref ref-type="bibr" rid="article-19213.r13">[13]</xref></p>
      </sec>
      <sec id="article-19213.s5" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>Ceruloplasmin has a molecular weight of 132kDa, and its crystal structure was identified in 1997. It is a polypeptide chain of 1046 amino acids with three asparagine-linked oligosaccharide side chains, and it contains a total carbohydrate content of 7&#x000a0;to 8%.<xref ref-type="bibr" rid="article-19213.r14">[14]</xref>&#x000a0;The size and charge of the molecule depend on the glycosylation of the molecule, the number of copper atoms, peptide chain variations, and polymerization.<xref ref-type="bibr" rid="article-19213.r15">[15]</xref>&#x000a0;Ceruloplasmin is highly prone to proteolysis; recent studies have utilized electron paramagnetic resonance spectroscopy techniques to evaluate its structure and concentration.<xref ref-type="bibr" rid="article-19213.r16">[16]</xref></p>
      </sec>
      <sec id="article-19213.s6" sec-type="Function">
        <title>Function</title>
        <p>The ceruloplasmin&#x000a0;molecule is a catalyst for redox reactions in plasma. It can oxidize iron from ferrous (2+) to ferric iron (3+), which assists in iron binding to transferrin. Neurological disorders in hereditary ceruloplasmin deficiency may be caused by disordered iron transport in the brain.&#x000a0;It is also thought to be involved in controlling membrane lipid oxidation. In the presence of superoxide, ceruloplasmin promotes LDL oxidation in vitro and is colocalized with oxidized LDL in atherosclerotic lesions.<xref ref-type="bibr" rid="article-19213.r17">[17]</xref>&#x000a0;The liver is the crucial organ in copper homeostasis, and more than 90% of the copper exported from the liver to the plasma is in the form of ceruloplasmin. However, ceruloplasmin's role in copper transport from the peripheral tissues is limited. Albumin is the main protein responsible for ionic copper transport from the tissues (such as absorbed copper in the digestive tract). The copper-albumin complex is directed to the liver via the portal system in circulation.&#x000a0;Albumin and transcuprein appear to be the other major copper transport proteins, especially immediately post-gastrointestinal absorption.<xref ref-type="bibr" rid="article-19213.r18">[18]</xref></p>
      </sec>
      <sec id="article-19213.s7" sec-type="Testing">
        <title>Testing</title>
        <p>Standard Ceruloplasmin measurement is via a blood test, often by analyzing a serum sample with&#x000a0;immunoassays, immunoturbidimetry, or immunonephelometry. The sample must be spun and separated as soon as the laboratory receives it and assays it promptly. The samples&#x000a0;may be stored at 4 degrees Celsius for up to three days or longer at -70 degrees Celsius. The serum test is often part of the workup when there is suspicion of Wilson disease and is commonly ordered&#x000a0;along with&#x000a0;urine copper levels. Several factors, including diet, hormone levels, and other genetic disorders, may influence the resulting ceruloplasmin levels in the urine and serum.<xref ref-type="bibr" rid="article-19213.r19">[19]</xref><xref ref-type="bibr" rid="article-19213.r20">[20]</xref></p>
        <p><bold>Deficiency States</bold>&#x000a0;</p>
        <p>Low ceruloplasmin levels may indicate the following pathological conditions: Wilson disease, Menke disease, copper&#x000a0;deficiency, aceruloplasminemia, or in states of low protein energy intake (eg, malnutrition.)<xref ref-type="bibr" rid="article-19213.r21">[21]</xref><xref ref-type="bibr" rid="article-19213.r22">[22]</xref></p>
        <p><bold>Excess</bold>&#x000a0;</p>
        <p>High ceruloplasmin levels may suggest or be present in physiological and pathological circumstances, including pregnancy,&#x000a0;oral contraceptive use, copper toxicity/zinc deficiency, lymphoma, lung cancer, acute and chronic inflammation, rheumatoid arthritis, angina, Alzheimer disease, schizophrenia, obsessive-compulsive disorder.<xref ref-type="bibr" rid="article-19213.r23">[23]</xref><xref ref-type="bibr" rid="article-19213.r24">[24]</xref><xref ref-type="bibr" rid="article-19213.r25">[25]</xref></p>
        <p><bold>Reference intervals </bold>(adapted from Tietz Textbook of Clinical Chemistry and Molecular Diagnostics by Carl A Burtis et al):</p>
        <p>
<bold>Age/Interval(mg/L)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cord (term): 50&#x000a0;to&#x000a0;330</p>
          </list-item>
          <list-item>
            <p>Birth&#x000a0;to 4 months: 150&#x000a0;to 560</p>
          </list-item>
          <list-item>
            <p>5&#x000a0;to 6 months: 260&#x000a0;to 830</p>
          </list-item>
          <list-item>
            <p>7&#x000a0;to 36 months: 310&#x000a0;to 900</p>
          </list-item>
          <list-item>
            <p>6&#x000a0;to 12 years: 250&#x000a0;to 450</p>
          </list-item>
        </list>
        <p>
<bold>Age/Male/Female</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>13&#x000a0;to 19 years: 150&#x000a0;to 370/220&#x000a0;to 500</p>
          </list-item>
          <list-item>
            <p>Adult: 220&#x000a0;to 400/250&#x000a0;to 600 (no oral contraceptives)</p>
          </list-item>
          <list-item>
            <p>Adult: 270&#x000a0;to 660 (on oral contraceptives, estrogens)</p>
          </list-item>
          <list-item>
            <p>Adult: 300&#x000a0;to 1200 (pregnant) See<bold> Image.</bold> Intervals and Interpretation&#x000a0;of&#x000a0;Ceruloplasmin.&#x000a0;</p>
          </list-item>
        </list>
        <p>Wilson disease is diagnosed based on clinical presentation, biochemical tests, and ATP7B mutation analysis. Regarding serum ceruloplasmin testing, only those&#x000a0;with low serum ceruloplasmin,&#x000a0;low serum copper, and high urine copper meet the criteria for Wilson disease. However, some patients diagnosed with Wilson disease exhibit normal ceruloplasmin levels. When urine and serum concentrations of copper and ceruloplasmin are low, the patient suffers from a copper deficiency. Factors interfering with&#x000a0;the body's ability to metabolize copper, such as chelator medications, diet, and iron restriction, may also affect serum ceruloplasmin levels.<xref ref-type="bibr" rid="article-19213.r26">[26]</xref><xref ref-type="bibr" rid="article-19213.r27">[27]</xref>&#x000a0;See <bold>Image.</bold>&#x000a0;Ceruloplasmin&#x000a0;Interpretation.</p>
      </sec>
      <sec id="article-19213.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Ceruloplasmin is undetectable before 20 weeks of gestation. Concentrations gradually rise to 25&#x000a0;to 40% of average adult concentrations and, by six months, are close to adult concentrations.<xref ref-type="bibr" rid="article-19213.r28">[28]</xref></p>
        <p>
<bold>Special Situations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>There have been reports of<italic toggle="yes"> inherited aceruloplasminemia</italic> in several families, and it is a genetic cause of ceruloplasmin deficiency; these patients have neurodegeneration and iron deposition in the brain.<xref ref-type="bibr" rid="article-19213.r29">[29]</xref>&#x000a0;Concerning aceruloplasminemia, a diagnosis of aceruloplasminemia could be suspected based upon a biochemical profile showing very low to absent ceruloplasmin in serum, high ferritin, low copper, low iron, microcytic anemia refractory to iron supplementation, and characteristic imaging features. Homozygous cases have distinctive imaging features with marked hypointensity of the liver, basal ganglia nuclei, thalami, dentate nuclei, and cerebral/cerebellar cortices on T2 MRI. MRI of heterozygous cases may reveal cerebellar atrophy without hypointensity of the basal ganglia.<xref ref-type="bibr" rid="article-19213.r30">[30]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Menkes disease</italic>&#x000a0;is an X-linked recessive disorder caused by a mutation in the ATP7A protein. With this mutation, copper cannot be transported out of the GI tract; therefore, copper is unavailable to the liver, which causes&#x000a0;low ceruloplasmin levels. The patients present in infancy have sparse, brittle, and kinky hair, growth retardation and neurologic degradation, and death if untreated in the first few years of life.<xref ref-type="bibr" rid="article-19213.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Wilson disease</italic>&#x000a0;results from an autosomal recessive mutation in the ATP7B protein. Mutations in ATP7B (located on chromosome 13) lead to Wilson disease. ATP7B is an efflux transporter in the liver, but it is also essential in the Trans-Golgi Network for transferring copper for the metalation of ceruloplasmin and biliary copper excretion.<xref ref-type="bibr" rid="article-19213.r32">[32]</xref>&#x000a0;The point mutation H1069Q is the most common ATP7B mutation in patients from Central, Eastern, and Northern Europe, and 50 to 80% of Wilson disease patients from these countries carry at least one H1069Q allele.<xref ref-type="bibr" rid="article-19213.r33">[33]</xref>&#x000a0;Mutations resulting in completely absent or non-functional ATP7B protein activity are associated with early-onset, typically hepatic, severe Wilson disease; these mutations are comparatively rare.<xref ref-type="bibr" rid="article-19213.r34">[34]</xref>&#x000a0;It is characterized by hepatolenticular degeneration due to copper deposition in organs, including the basal ganglia, cornea, and liver.&#x000a0;In Wilson's disease, ceruloplasmin levels are usually low, but urinary excretion of copper is high. Liver biopsy results show high copper content. Clinically, a dark ring around the iris suggests a diagnosis of Wilson disease. This sign is known as a Kayser-Fleischer ring.<xref ref-type="bibr" rid="article-19213.r35">[35]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19213.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Treatment for Aceruloplasmin and Wilson Disease</bold>
</p>
        <p>Treatment for aceruloplasminemia mainly involves chelation therapy and increasing serum ceruloplasmin. Fresh-frozen plasma, which contains ceruloplasmin combined with IV desferrioxamine, effectively decreases iron content in the liver. Repetitive&#x000a0;fresh-frozen plasma&#x000a0;treatment can improve neurologic signs/symptoms. Treatment options for Wilson disease include chelation therapy (D-penicillamine, trientine, and tetrathiomolybdate) or zinc salts. Medical therapy is continued lifelong as copper accumulation is not manageable with dietary restriction alone. It is important to note that there may be an associated paradoxical worsening of neurological status after initiation of chelation therapy. While this is not fully understood, studies suggest that increased mobilization of free copper by chelator therapy may lead to acute worsening upon initiation of treatment.<xref ref-type="bibr" rid="article-19213.r34">[34]</xref></p>
        <p>
<bold>Complications</bold>
</p>
        <p>Diabetes mellitus, ataxia, dystonia, Parkinsonism, psychiatric problems (mostly mood disorders), cardiac disease, thyroid dyscrasia, anemia, and liver damage are common complications shared by both Wilson disease and aceruloplasminemia. Amenorrhea and frequent abortions may be complications of copper toxicity that may affect fertility. Antipsychotic drugs are applied in severe mania and to treat psychotic symptoms. In Wilson disease, antipsychotics increase the risk of neurological deterioration and hepatic injury. As such, antipsychotics with low EPS risk, such as clozapine or quetiapine, should be used.<xref ref-type="bibr" rid="article-19213.r36">[36]</xref></p>
        <p>
<bold>Enhancing Healthcare Team Outcomes</bold>
</p>
        <p>Surveillance should include yearly glucose tolerance tests starting at the age of 15 or the age of diagnosis if, after 15 years old, to monitor for the inception of diabetes mellitus. Regular eye exams should also be a consideration, as retinopathy is a prominent feature in aceruloplasminemia and Wilson&#x000a0;disease. An annual echocardiogram, thyroid and liver function evaluation, and a complete blood count (CBC) starting at the diagnosis should be performed to monitor for other potential complications. Blood transfusions should be approached cautiously as the increased iron load may be challenging for patients with these disorders. In patients with Wilson disease, it is strongly recommended that familial screening is performed. The American Association for Study of Liver Diseases and the European Association for the Study of Liver both separately recommend screening first-degree relatives of the affected individuals, suggesting siblings or offspring only.<xref ref-type="bibr" rid="article-19213.r37">[37]</xref>&#x000a0;While most patients with Wilson disease who become pregnant have successful pregnancies, a discussion is necessary about the potential side effects of anti-copper therapy, as all available anti-copper drugs can pass into the breast.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
        <p><bold>Ceruloplasmin Interpretation Adapted from Labtestsonline</bold>&#x000a0;[See exhibit 2]</p>
        <p>
<bold>Wilson disease</bold>
</p>
        <p>Wilson disease presents between ages 5&#x000a0;to 35<bold>.</bold><xref ref-type="bibr" rid="article-19213.r38">[38]</xref></p>
        <p>The clinical presentation may include the following symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hepatolenticular degeneration</p>
          </list-item>
          <list-item>
            <p>Kayser-Fleischer rings</p>
          </list-item>
          <list-item>
            <p>Parkinsonism</p>
          </list-item>
          <list-item>
            <p>Ataxia</p>
          </list-item>
          <list-item>
            <p>Personality changes</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Psychosis</p>
          </list-item>
          <list-item>
            <p>Acute&#x000a0;liver failure</p>
          </list-item>
          <list-item>
            <p>Chronic liver failure</p>
          </list-item>
          <list-item>
            <p>Cirrhosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Renal issues (renal tubular acidosis with aminoaciduria)</p>
          </list-item>
          <list-item>
            <p>Secondary Hemolysis is less common</p>
          </list-item>
          <list-item>
            <p>Most patients with Wilson&#x000a0;disease have low ceruloplasmin levels</p>
          </list-item>
        </list>
        <p>Treatment may include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Penicillamine</p>
          </list-item>
          <list-item>
            <p>Trientine</p>
          </list-item>
          <list-item>
            <p>Zinc&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19213.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19213&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19213">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19213/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19213">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19213.s11">
        <fig id="article-19213.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Intervals and Interpretation of Ceruloplasmin&#x000a0; Contributed by R Sirkar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Rivindra__Sirkar__Tables" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19213.s12">
        <fig id="article-19213.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Ceruloplasmin&#x000a0;Interpretation Contributed by M Lopez, BS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Ceruloplasmin__Table__01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19213.s13">
        <title>References</title>
        <ref id="article-19213.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walshe</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Cause of death in Wilson disease.</article-title>
            <source>Mov Disord</source>
            <year>2007</year>
            <month>Nov</month>
            <day>15</day>
            <volume>22</volume>
            <issue>15</issue>
            <fpage>2216</fpage>
            <page-range>2216-20</page-range>
            <pub-id pub-id-type="pmid">17712859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasilyev</surname>
                <given-names>VB</given-names>
              </name>
            </person-group>
            <article-title>Interactions of caeruloplasmin with other proteins participating in inflammation.</article-title>
            <source>Biochem Soc Trans</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>947</fpage>
            <page-range>947-51</page-range>
            <pub-id pub-id-type="pmid">20658982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Twomey</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Viljoen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>House</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Wierzbicki</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice.</article-title>
            <source>Clin Chem</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>8</issue>
            <fpage>1558</fpage>
            <page-range>1558-9</page-range>
            <pub-id pub-id-type="pmid">16040861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Squitti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quattrocchi</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Forno</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Antuono</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wekstein</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Capo</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Salustri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rossini</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.</article-title>
            <source>Biomark Insights</source>
            <year>2007</year>
            <month>Feb</month>
            <day>07</day>
            <volume>1</volume>
            <fpage>205</fpage>
            <page-range>205-13</page-range>
            <pub-id pub-id-type="pmid">19690651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Squitti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quattrocchi</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Salustri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rossini</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.</article-title>
            <source>Prion</source>
            <year>2008</year>
            <season>Jan-Mar</season>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-7</page-range>
            <pub-id pub-id-type="pmid">19164917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharp</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The molecular basis of copper and iron interactions.</article-title>
            <source>Proc Nutr Soc</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>563</fpage>
            <page-range>563-9</page-range>
            <pub-id pub-id-type="pmid">15831128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maio</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Polticelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Francesco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bonaccorsi di Patti</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Musci</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Role of external loops of human ceruloplasmin in copper loading by ATP7B and Ccc2p.</article-title>
            <source>J Biol Chem</source>
            <year>2010</year>
            <month>Jul</month>
            <day>02</day>
            <volume>285</volume>
            <issue>27</issue>
            <fpage>20507</fpage>
            <page-range>20507-13</page-range>
            <pub-id pub-id-type="pmid">20430895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharonov</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Govorova</surname>
                <given-names>NIu</given-names>
              </name>
            </person-group>
            <article-title>[Oxidation of ceruloplasmin by hypochlorite. The loss of blue color and preservation of oxidase activity].</article-title>
            <source>Biokhimiia</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>1145</fpage>
            <page-range>1145-8</page-range>
            <pub-id pub-id-type="pmid">2169906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hurd</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Van Rinsvelt</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Wilder</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Karas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maenhaut</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>De Reu</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects.</article-title>
            <source>Neurology</source>
            <year>1984</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>10</issue>
            <fpage>1393</fpage>
            <page-range>1393-5</page-range>
            <pub-id pub-id-type="pmid">6435012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aggarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Wilson disease.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>534</fpage>
            <page-range>534-542</page-range>
            <pub-id pub-id-type="pmid">32657896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vlasova</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Sokolov</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Kostevich</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Mikhalchik</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Vasilyev</surname>
                <given-names>VB</given-names>
              </name>
            </person-group>
            <article-title>Myeloperoxidase-Induced Oxidation of Albumin and Ceruloplasmin: Role of Tyrosines.</article-title>
            <source>Biochemistry (Mosc)</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>652</fpage>
            <page-range>652-662</page-range>
            <pub-id pub-id-type="pmid">31238865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sahoo</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Ceruloplasmin, a moonlighting protein in fish.</article-title>
            <source>Fish Shellfish Immunol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>82</volume>
            <fpage>460</fpage>
            <page-range>460-468</page-range>
            <pub-id pub-id-type="pmid">30144565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Linder</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Apoceruloplasmin: Abundance, Detection, Formation, and Metabolism.</article-title>
            <source>Biomedicines</source>
            <year>2021</year>
            <month>Feb</month>
            <day>25</day>
            <volume>9</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33669134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bento</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Peixoto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zaitsev</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Lindley</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites.</article-title>
            <source>Acta Crystallogr D Biol Crystallogr</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>Pt 2</issue>
            <fpage>240</fpage>
            <page-range>240-8</page-range>
            <pub-id pub-id-type="pmid">17242517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harazono</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ishii-Watabe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kawanishi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hayakawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Site-specific N-glycosylation analysis of human plasma ceruloplasmin using liquid chromatography with electrospray ionization tandem mass spectrometry.</article-title>
            <source>Anal Biochem</source>
            <year>2006</year>
            <month>Jan</month>
            <day>15</day>
            <volume>348</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-68</page-range>
            <pub-id pub-id-type="pmid">16321355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibragimova</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Chushnikov</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Moiseev</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Petukhov</surname>
                <given-names>VIu</given-names>
              </name>
              <name>
                <surname>Zheglov</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Pogorel'tsev</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Khardina</surname>
                <given-names>NB</given-names>
              </name>
            </person-group>
            <article-title>[Electron paramagnetic resonance determination of ceruloplasmin concentration in the blood of patients for the diagnosis of urological cancer diseases].</article-title>
            <source>Klin Lab Diagn</source>
            <year>2010</year>
            <month>Apr</month>
            <issue>4</issue>
            <fpage>17</fpage>
            <page-range>17-20</page-range>
            <pub-id pub-id-type="pmid">20524342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levitan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Volkov</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Subbaiah</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>Oxidized LDL: diversity, patterns of recognition, and pathophysiology.</article-title>
            <source>Antioxid Redox Signal</source>
            <year>2010</year>
            <month>Jul</month>
            <day>01</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-75</page-range>
            <pub-id pub-id-type="pmid">19888833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moriya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Grana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jamil</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ackland</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Michalczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism.</article-title>
            <source>Am J Physiol Cell Physiol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>295</volume>
            <issue>3</issue>
            <fpage>C708</fpage>
            <page-range>C708-21</page-range>
            <pub-id pub-id-type="pmid">18579803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez-Jim&#x000e9;nez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schmidt-Riovalle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sinaus&#x000ed;a</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carmen Valenza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perona</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Predictive value of ceruloplasmin for metabolic syndrome in adolescents.</article-title>
            <source>Biofactors</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>163</fpage>
            <page-range>163-70</page-range>
            <pub-id pub-id-type="pmid">27083758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nagae</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moriyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azuma</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Effects of prolactin and growth hormone on plasma immunoglobulin M levels of hypophysectomized rainbow trout, Oncorhynchus mykiss.</article-title>
            <source>Gen Comp Endocrinol</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-52</page-range>
            <pub-id pub-id-type="pmid">10375463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hermann</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Classification and differential diagnosis of Wilson's disease.</article-title>
            <source>Ann Transl Med</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>Suppl 2</issue>
            <fpage>S63</fpage>
            <pub-id pub-id-type="pmid">31179300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gautam</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deb</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Akhter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shahidullah</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hoque</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Serum zinc and copper level in children with protein energy malnutrition.</article-title>
            <source>Mymensingh Med J</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>2 Suppl</issue>
            <fpage>S12</fpage>
            <page-range>S12-5</page-range>
            <pub-id pub-id-type="pmid">18946444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Sareen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Khandelwal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Serum copper and ceruloplasmin in pregnancy with anaemia.</article-title>
            <source>Indian J Pathol Microbiol</source>
            <year>1989</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-32</page-range>
            <pub-id pub-id-type="pmid">2592032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esme</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cemek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sezer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saglam</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Melek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Unlu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>High levels of oxidative stress in patients with advanced lung cancer.</article-title>
            <source>Respirology</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-6</page-range>
            <pub-id pub-id-type="pmid">18197920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Kotun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meador-Woodruff</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.</article-title>
            <source>Schizophr Res</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>1-3</issue>
            <fpage>167</fpage>
            <page-range>167-71</page-range>
            <pub-id pub-id-type="pmid">16842975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manolaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nikolopoulou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Daikos</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Panagiotakaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tzetis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kanavakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Syriopoulou</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Wilson disease in children: analysis of 57 cases.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-7</page-range>
            <pub-id pub-id-type="pmid">19172127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Merle</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferenci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fullekrug</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stremmel</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels.</article-title>
            <source>World J Gastroenterol</source>
            <year>2006</year>
            <month>Apr</month>
            <day>14</day>
            <volume>12</volume>
            <issue>14</issue>
            <fpage>2239</fpage>
            <page-range>2239-42</page-range>
            <pub-id pub-id-type="pmid">16610028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kroll</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Ferber</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Mensink</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Lorey</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sherwin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rinaldo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Matern</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease.</article-title>
            <source>Mol Genet Metab</source>
            <year>2006</year>
            <season>Sep-Oct</season>
            <volume>89</volume>
            <issue>1-2</issue>
            <fpage>134</fpage>
            <page-range>134-8</page-range>
            <pub-id pub-id-type="pmid">16644258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Miyajima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hosoi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <chapter-title>Aceruloplasminemia</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2003</year>
            <month>8</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">20301666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNeill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pandolfo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuhn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miyajima</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The neurological presentation of ceruloplasmin gene mutations.</article-title>
            <source>Eur Neurol</source>
            <year>2008</year>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>200</fpage>
            <page-range>200-5</page-range>
            <pub-id pub-id-type="pmid">18667828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jafri</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lashari</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Chand</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Menkes disease: A rare disorder.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>1609</fpage>
            <page-range>1609-1611</page-range>
            <pub-id pub-id-type="pmid">28955085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prohaska</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Role of copper transporters in copper homeostasis.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>826S</fpage>
            <page-range>826S-9S</page-range>
            <pub-id pub-id-type="pmid">18779302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferenci</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing.</article-title>
            <source>Hum Genet</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-9</page-range>
            <pub-id pub-id-type="pmid">16791614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandmann</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kaler</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Wilson's disease and other neurological copper disorders.</article-title>
            <source>Lancet Neurol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-13</page-range>
            <pub-id pub-id-type="pmid">25496901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Low</surname>
                <given-names>QJ</given-names>
              </name>
              <name>
                <surname>Siaw</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cheo</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Kayser-Fleischer rings and Wilson's disease.</article-title>
            <source>QJM</source>
            <year>2020</year>
            <month>Sep</month>
            <day>01</day>
            <volume>113</volume>
            <issue>9</issue>
            <fpage>693</fpage>
            <page-range>693-694</page-range>
            <pub-id pub-id-type="pmid">31917404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cz&#x00142;onkowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Litwin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dusek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ferenci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lutsenko</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Medici</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rybakowski</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Schilsky</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Wilson disease.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2018</year>
            <month>Sep</month>
            <day>06</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <pub-id pub-id-type="pmid">30190489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>97</volume>
            <issue>27</issue>
            <fpage>e11405</fpage>
            <pub-id pub-id-type="pmid">29979436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19213.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mare&#x0010d;ek</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Br&#x0016f;ha</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Wilsons disease].</article-title>
            <source>Vnitr Lek</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>59</volume>
            <issue>7</issue>
            <fpage>578</fpage>
            <page-range>578-83</page-range>
            <pub-id pub-id-type="pmid">23909262</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
